Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H25N2OS.Cl |
Molecular Weight | 364.933 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)[N+](C)(C)CCO
InChI
InChIKey=FUFHLEMGRBXVCF-UHFFFAOYSA-M
InChI=1S/C19H25N2OS.ClH/c1-15(21(2,3)12-13-22)14-20-16-8-4-6-10-18(16)23-19-11-7-5-9-17(19)20;/h4-11,15,22H,12-14H2,1-3H3;1H/q+1;/p-1
Molecular Formula | C19H24N2OS |
Molecular Weight | 328.472 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/4386346
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4386346
Promethazine hydroxyethyl quaternary derivative of promethazine with antihistamine and anticholinergic properties. The drug lacked the sedative properties of promethazine. It was used in the clinic under tradename Aprobit.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:44:08 GMT 2023
by
admin
on
Sat Dec 16 10:44:08 GMT 2023
|
Record UNII |
O3842T8RNK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000085088
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | |||
|
DTXSID70875166
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | |||
|
2090-54-2
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | |||
|
16405
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | |||
|
m240
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB04071MIG
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | |||
|
35517-04-5
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
SUPERSEDED | |||
|
O3842T8RNK
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
PRIMARY | |||
|
73706-86-2
Created by
admin on Sat Dec 16 10:44:08 GMT 2023 , Edited by admin on Sat Dec 16 10:44:08 GMT 2023
|
SUPERSEDED |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |